Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LAB
|
Nicolas Barthelemy
Director |
BUY
Exercise of conversion of derivative security
|
Indirect | 5,000 Added 2.66% |
$17,150
$3.43 p/Share
|
Mar 31
2022 |
PCYN
|
Foundation Speer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 2.67% |
$15,200
$0.38 p/Share
|
Mar 31
2022 |
STRR
|
Michael A. Cunnion
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,885 Added 5.83% |
-
|
Mar 31
2022 |
STRR
|
Jeffrey E. Eberwein
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 34,937 Added 1.75% |
-
|
Mar 31
2022 |
STRR
|
Mitchell I Quain
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,885 Added 6.95% |
-
|
Mar 31
2022 |
STRR
|
John W. Sayward
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,885 Added 6.33% |
-
|
Mar 31
2022 |
SSNT
|
Mark Meller
Pres., SilverSun Technologies |
BUY
Bona fide gift
|
Indirect | 800,000 Added 50.0% |
-
|
Mar 31
2022 |
SSNT
|
Mark Meller
Pres., SilverSun Technologies |
SELL
Bona fide gift
|
Direct | 800,000 Reduced 66.31% |
-
|
Mar 31
2022 |
EDSA
|
Pardeep Nijhawan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.35% |
$5,980
$2.99 p/Share
|
Mar 31
2022 |
GVP
|
Kyle Justin Loudermilk
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,878 Reduced 1.76% |
$24,706
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Daniel Warren Pugh
Chief Legal and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,371 Reduced 1.37% |
$2,852
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Emmett Anthony Pepe
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,129 Reduced 1.22% |
$6,508
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Ravi Khanna
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 848 Reduced 1.22% |
$1,764
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Donald Horn
President, GSE Engineering |
SELL
Payment of exercise price or tax liability
|
Direct | 1,215 Reduced 2.71% |
$2,527
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Brian Greene
VP, GSE Workforce Solutions |
SELL
Payment of exercise price or tax liability
|
Direct | 978 Reduced 3.33% |
$2,034
$2.08 p/Share
|
Mar 31
2022 |
GVP
|
Bahram Meyssami
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,554 Reduced 0.72% |
$3,232
$2.08 p/Share
|
Mar 31
2022 |
MNPR
|
Michael J Brown
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,859 Added 1.3% |
-
|
Mar 31
2022 |
MNPR
|
Raymond Anderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,859 Added 25.96% |
-
|
Mar 31
2022 |
MNPR
|
Christopher M Starr
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,859 Added 28.56% |
-
|
Mar 31
2022 |
MNPR
|
Arthur J Klausner
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,859 Added 19.04% |
-
|
Mar 31
2022 |
MNPR
|
Kim R Tsuchimoto
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 500 Reduced 8.15% |
$1,275
$2.55 p/Share
|
Mar 31
2022 |
MNPR
|
Kim R Tsuchimoto
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,221 Added 16.6% |
-
|
Mar 31
2022 |
MNPR
|
Andrew Paul Mazar
Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 471 Reduced 2.08% |
$1,201
$2.55 p/Share
|
Mar 31
2022 |
MNPR
|
Andrew Paul Mazar
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,606 Added 6.64% |
-
|
Mar 31
2022 |
MNPR
|
Chandler Robinson
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,155 Reduced 3.07% |
$2,945
$2.55 p/Share
|
Mar 31
2022 |
MNPR
|
Chandler Robinson
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,941 Added 9.47% |
-
|
Mar 31
2022 |
UBX
|
Jamie Dananberg
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,188 Reduced 0.6% |
$4,774
$1.14 p/Share
|
Mar 31
2022 |
UBX
|
Anirvan Ghosh
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 14,472 Reduced 1.37% |
$16,498
$1.14 p/Share
|
Mar 31
2022 |
JANL
|
John Eidinger
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct | 65,205 Added 27.64% |
$3,064,635
$47.0 p/Share
|
Mar 31
2022 |
WTER
|
David Guarino
CFO, Secretary and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 3.99% |
-
|
Mar 31
2022 |
WTER
|
Aaron Keay |
BUY
Grant, award, or other acquisition
|
Direct | 150,000 Added 16.67% |
-
|
Mar 31
2022 |
WTER
|
Frank Lazaran
Director |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 12.3% |
-
|
Mar 31
2022 |
WTER
|
Richard A Wright
President VP CEO COO |
BUY
Grant, award, or other acquisition
|
Direct | 150,000 Added 3.37% |
-
|
Mar 31
2022 |
WTER
|
Brian Sudano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 25,000 Added 22.22% |
-
|
Mar 31
2022 |
BRLT
|
Jennifer Noel Harris
Director |
BUY
Grant, award, or other acquisition
|
Direct | 859 Added 7.73% |
-
|
Mar 31
2022 |
BRLT
|
Jeffrey Chuenhong Kuo
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,800 Added 1.1% |
-
|
Mar 31
2022 |
BRLT
|
Attica Jaques
Director |
BUY
Grant, award, or other acquisition
|
Direct | 571 Added 9.12% |
-
|
Mar 31
2022 |
BRLT
|
Ian Bickley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 571 Added 9.12% |
-
|
Mar 31
2022 |
BRLT
|
Beth J Kaplan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,116 Added 5.31% |
-
|
Mar 31
2022 |
CRVS
|
Richard A Md Miller
President and CEO |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 1.11% |
$24,600
$1.64 p/Share
|
Mar 31
2022 |
MTBC
|
John N Daly
Director |
SELL
Bona fide gift
|
Direct | 400 Reduced 0.95% |
-
|
Mar 31
2022 |
MTBC
|
John N Daly
Director |
SELL
Open market or private sale
|
Direct | 4,350 Reduced 9.41% |
$22,490
$5.17 p/Share
|
Mar 31
2022 |
CAPR
|
Louis Manzo |
SELL
Payment of exercise price or tax liability
|
Direct | 11,309 Reduced 40.53% |
$38,790
$3.43 p/Share
|
Mar 31
2022 |
CAPR
|
Louis Manzo |
BUY
Exercise of conversion of derivative security
|
Direct | 27,904 Added 50.0% |
$38,787
$1.39 p/Share
|
Mar 31
2022 |
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,797
$4.29 p/Share
|
Mar 31
2022 |
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,797
$4.29 p/Share
|
Mar 31
2022 |
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$11,797
$4.29 p/Share
|
Mar 31
2022 |
TELA
|
Antony Koblish
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 384 Reduced 0.16% |
$4,466
$11.63 p/Share
|
Mar 31
2022 |
TELA
|
Peter C. Murphy
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 163 Reduced 0.7% |
$1,896
$11.63 p/Share
|
Mar 31
2022 |
TELA
|
Paul Talmo
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 185 Reduced 0.44% |
$2,152
$11.63 p/Share
|
Mar 31
2022 |